PUBLIKATIONSLISTE 2005
| Afdelingens | |
Medicinsk Forskning, Holstebro Sygehus
Formidling
Anmeldelse i tidsskrift
Pedersen, EB 2005, 'Anmeldelse af Dialyse. 2.udgave, Eidemark I, Bro S, red. Fadls Forlag, 2005' Ugeskr Laeger 2005; 167: 4683-4684.
Forskning
Artikel
Andersen, C, Gruszka-Westwood, A, Atkinson, S, Matutes, E, Catovsky, D, Pedersen, R, Pedersen, B, Pulczynski, S, Hokland, P, Jacobsen, E, & Koch, J 2005, 'Recurrent genomic imbalances in B-cell splenic marginal-zone lymphoma revealed' Cancer Genet Cytogenet, nr. 156, s. 122-128.
Daugaard, G, Lassen, U, Bie, P, Pedersen, E, Jensen, K, Abildgaard, U, Hesse, B, & Kjaer, A 2005, 'Natriuretic peptides in the monitoring of anthracycline induced reduction in' Eur. J. Heart Fail, nr. 7, s. 87-93.
Starklint, J, Bech, J, & Pedersen, E 2005, 'Down-regulation of urinary AQP2 and unaffected response to hypertonic saline after 24 hours of fasting in humans' Kidney Int. 2005;67:1010-8., nr. 67, s. 1010-1018.
Artikel peer reviewed
Delmar, C, Bøje, T, Dylmer, D, Forup, L, Jakobsen, C, Møller, M, Sønder, H, & Pedersen, B 2005, 'Schieving harmony with oneself; life with a chronic illness.' Scand J Caring Sci. 2005;19:204-212..
Jensen, B, Abildstrøm, S, Larroude, C, Agner, E, Torp-Pedersen, C, Nyvad, O, Ottesen, M, Wachtell, K, & Kanters, J 2005, 'QT dynamics in risk stratification after myocardial infarction' Heart Rhythm. 2005;2:357-64.
Pedersen, E, Jørgensen, M, Pedersen, M, Siggaard, C, Sørensen, T, Mulvad, G, Hansen, J, Asmund, G, & Skjoldborg, H 2005, 'Relationship between mercury in blood and 24-h ambulatory blood pressure in Greenlanders and Danes' Am J Hypertens. 2005;18: 612-8..
Pedersen, E, Thomsen, I, & Fjordside, L 2005, 'Effect of BQ-123, an endothelin antagonist, on renal hemodynamics, tubular function, vasoactive hormones, and blood pressure in healthy humans: a dose response study' Am J Hypertens. 2005;18:1578-85.
Pedersen, T, Faergeman, O, Kastelein, J, Olsson, A, Holme, I, Tikkanen, M, Larsen, M, Bendiksen, F, Lindahl, C, Szarek, M, & Tsai, J 2005, 'Incremental Decrease in End Points Through Aggressive Lipid Lowering (IDEAL) Study Group. High Dose atorvastatin vs usual-dose simvastatin for secondary prevention after myocardial infarction: the IDEAL Study: a randomized controlled trial. Multicenterstudium' JAMA, nr. 294, s. 2437-45.
Siggaard, C, Christensen, JH, Corydon, TJ, Rittig, S, Robertson, GL, Gregersen, N, Bolund, L, & Pedersen, EB 2005, 'Expression of three different mutations in the arginine vasopressin gene suggests genotype-phenotype correlation in familial neurohypophyseal diabetes insipidus kindreds.' Clinical Endocrinology, vol. 63, nr. 2, s. 207-216.
Starklint, J, Bech, J, & Pedersen, E 2005, 'Urinary excretion of aquaporin-2 after furosemide and felodipine in healthy humans' Scand J Clin Lab Invest. 2005;65:249-61.
Svendsen, K, Ellingsen, T, Bech, J, Jensen, MP, Stengaard-Pedersen, K, & Pedersen, EB 2005, 'Urinary excretion of alpha-GST and albumin in rheumatoid arthritis patientstreated with methotrexate or other DMARDs alone or in combination with NSAIDs' Scand J Rheumatol, vol. 34, nr. 1, s. 34-9.
Ph.d.-afhandling
Starklint, J 2005, 'Aquaporin 2 excretion in urine in humans. A study of urinary aquaporin 2 excretion after felodipine, furosemide, and fasting in healthy humans, and after furosemid in patients with chronic heart failure. Ph.d. afhandling.' Ph.d.-afhandling, Aarhus Universitet.




